Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Foti

Showing results (181-190 of 183) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 183 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 12, 2022
Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experienceL Stingeni, L Bianchi, E Antonelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 26, 2025
Tirbanibulin 1% real-world use in 679 actinic keratoses patients during warm season (SUMM-AK study)A Carugno, G Nazzaro, L Argnani, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 9, 2024
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian studyB M Piraccini, F Pampaloni, S Cedirian, et al.
Pageof 19

Showing results (181-190 of 183) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 183 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 12, 2022
Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experienceL Stingeni, L Bianchi, E Antonelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 26, 2025
Tirbanibulin 1% real-world use in 679 actinic keratoses patients during warm season (SUMM-AK study)A Carugno, G Nazzaro, L Argnani, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 9, 2024
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian studyB M Piraccini, F Pampaloni, S Cedirian, et al.
Pageof 19